{"id":41022,"date":"2023-12-28T18:33:10","date_gmt":"2023-12-28T18:33:10","guid":{"rendered":"https:\/\/news.pakistaninewspaperlist.com\/investigation-into-milestone-pharmaceuticals-inc-mist-announced-by-holzer-holzer-llc\/"},"modified":"2023-12-28T18:33:10","modified_gmt":"2023-12-28T18:33:10","slug":"investigation-into-milestone-pharmaceuticals-inc-mist-announced-by-holzer-holzer-llc","status":"publish","type":"post","link":"https:\/\/pakistaninewspaperlist.com\/news\/investigation-into-milestone-pharmaceuticals-inc-mist-announced-by-holzer-holzer-llc\/","title":{"rendered":"Investigation Into Milestone Pharmaceuticals Inc. (MIST) Announced by Holzer &#038; Holzer, LLC"},"content":{"rendered":"<div id=\"main-body-container\" itemprop=\"articleBody\">\n<p align=\"justify\">ATLANTA, Dec.  28, 2023  (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC is investigating whether Milestone Pharmaceuticals Inc. (\u201cMilestone Pharmaceuticals\u201d or the \u201cCompany\u201d) (NASDAQ: MIST) complied with federal securities laws.\u00a0 On December 26, 2023, the Company disclosed it had received a Refusal to File (\u201cRTF\u201d) letter from the U.S. Food and Drug Administration (\u201cFDA\u201d) for its New Drug Application (\u201cNDA\u201d) for Etripamil. During preliminary review of the NDA, the FDA determined it \u201cwas not sufficiently complete to permit substantive review\u201d and \u201crequested clarification about the time of data recorded for adverse events in Phase 3 clinical trials.\u201d Following this news, the price of the Company\u2019s stock dropped.\u00a0<\/p>\n<p align=\"justify\">If you purchased Milestone Pharmaceuticals stock and suffered\u202fa\u202floss on that investment, you are encouraged to contact Corey Holzer, Esq. at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zXxCqEk-QMa9K2S1Muf9hA9PzI6IY4SuZk9zbD8srcgOBXpqxB35WAryfyttQrKDvUetcH6qjZPlyH5IicnyhicBNaJdMMzExFsNL8EzCSg=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"cholzer@holzerlaw.com\">cholzer@holzerlaw.com<\/a> or Joshua Karr, Esq. at\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=y8L-t1pstqMkcdX3DU5oinYMhFEBbJ71qP3VsDUgTcvu5RyQRnJbcOnMsUHxMr_l-jHaf51EjtLpUqbKK0pIleQ-ZjifS6Jjk7xE0_A8Pps=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><u>jkarr@holzerlaw.com<\/u><\/a>, call our toll-free number at (888) 508-6832, or visit our website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EbTMReuICGq5BMwTRKjxIrkAI9Sgu6NTnhpxSFn-cTKh6BlJmEL4Om294BA6ia51ohnMYkCC4mGWnpXq6DN7vKUtHVGpOyTYw94ir9rHmVHpaWbBNtJdAdvCYV9OScnsBIaa0A93_oDbhLXeqrsBXfo6QuuHz05UHn9Cizt65Ekhup-iWQhl4c00QtuzhJPZ\" rel=\"nofollow noopener\" target=\"_blank\" title=\"www.holzerlaw.com\/case\/milestone-pharmaceuticals\/\">www.holzerlaw.com\/case\/milestone-pharmaceuticals\/<\/a> to discuss your legal rights.\u00a0\u00a0\u00a0<\/p>\n<p align=\"justify\">Holzer &amp; Holzer, LLC, an ISS top rated securities litigation law firm for 2021 and 2022, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer &amp; Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct.\u202fMore information about the firm is available through its website, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EbTMReuICGq5BMwTRKjxIkCd2XJaJe45SyLZ5fFbeNqaL9LRfvvGF9EtuNzNnNGMvXUihN4pz7AtYt0nSn12IQ==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><u>www.holzerlaw.com<\/u><\/a>,\u202fand upon request from the firm. Holzer &amp; Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.\u202f\u00a0<br \/>\u202f\u00a0<br \/>CONTACT:\u202f\u00a0<br \/>Corey Holzer, Esq.<br \/>(888) 508-6832 (toll-free) <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zXxCqEk-QMa9K2S1Muf9hA9PzI6IY4SuZk9zbD8srcgf6jvbQig0zsEIpHiQF4lY_P3ytkIQ-MGugsnLIkn410th3bJMC3PcOfteg9nDP50=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"cholzer@holzerlaw.com\">cholzer@holzerlaw.com<\/a><\/p>\n<p>\n            <\/div>\n","protected":false},"excerpt":{"rendered":"<p>ATLANTA, Dec. 28, 2023 (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC is investigating whether Milestone Pharmaceuticals Inc. (\u201cMilestone Pharmaceuticals\u201d or the \u201cCompany\u201d) (NASDAQ: MIST) complied with federal securities laws.\u00a0 On December 26, 2023, the Company disclosed it had received a Refusal to File (\u201cRTF\u201d) letter from the U.S. Food and Drug Administration (\u201cFDA\u201d) for its [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":41023,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"fifu_image_url":"https:\/\/ml.globenewswire.com\/Resource\/Download\/ded75474-e608-4c33-b664-8dc46382852f","fifu_image_alt":"","footnotes":""},"categories":[208],"tags":[],"class_list":["post-41022","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-globenewswire"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/posts\/41022","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/comments?post=41022"}],"version-history":[{"count":0,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/posts\/41022\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/media\/41023"}],"wp:attachment":[{"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/media?parent=41022"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/categories?post=41022"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/tags?post=41022"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}